{"id":"insulatard-flexpen","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL2108973","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulatard is a neutral protamine Hagedorn (NPH) insulin formulation, a suspension of insulin crystals complexed with protamine that delays absorption from the subcutaneous injection site. This extended-release profile allows for once or twice daily dosing to provide steady background insulin levels, mimicking the pancreas's basal insulin secretion. It is typically used in combination with rapid-acting insulins to achieve comprehensive glycemic control.","oneSentence":"Insulatard is a long-acting insulin suspension that provides basal insulin coverage by slowly releasing insulin to maintain blood glucose control between meals and overnight.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:05.534Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT00625781","phase":"NA","title":"Treatment of Impaired Glucose Tolerance in Pregnancy","status":"COMPLETED","sponsor":"Region Örebro County","startDate":"2008-02","conditions":"Impaired Glucose Tolerance, Fetal Macrosomia","enrollment":72},{"nctId":"NCT00329615","phase":"PHASE4","title":"Insulin Treatment in Cancer Cachexia","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2000-01","conditions":"Cancer Cachexia","enrollment":135}],"_emaApprovals":[],"_faersSignals":[{"count":23,"reaction":"HYPOGLYCAEMIA"},{"count":7,"reaction":"DIZZINESS"},{"count":7,"reaction":"DYSPNOEA"},{"count":7,"reaction":"MALAISE"},{"count":7,"reaction":"NAUSEA"},{"count":6,"reaction":"FALL"},{"count":6,"reaction":"LACTIC ACIDOSIS"},{"count":6,"reaction":"LOSS OF CONSCIOUSNESS"},{"count":6,"reaction":"PREMATURE BABY"},{"count":6,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Insulatard, flexpen","genericName":"Insulatard, flexpen","companyName":"Göteborg University","companyId":"g-teborg-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulatard is a long-acting insulin suspension that provides basal insulin coverage by slowly releasing insulin to maintain blood glucose control between meals and overnight. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}